-
1
-
-
33846260566
-
Sorafenib for the treatment of advanced renal cell carcinoma
-
Kane RC, Farrell AT, Saber H, Tang S, Williams G, Jee JM, et al. Sorafenib for the treatment of advanced renal cell carcinoma. Clin Cancer Res 2006;12:7271-7278
-
(2006)
Clin Cancer Res
, vol.12
, pp. 7271-7278
-
-
Kane, R.C.1
Farrell, A.T.2
Saber, H.3
Tang, S.4
Williams, G.5
Jee, J.M.6
-
2
-
-
33749017926
-
Phase II study of sorafenib in patients with advanced hepatocellular carcinoma
-
Abou-Alfa GK, Schwartz L, Ricci S, Amadori D, Santoro A, Figer A, et al. Phase II study of sorafenib in patients with advanced hepatocellular carcinoma. J Clin Oncol 2006;24:4293-4300
-
(2006)
J Clin Oncol
, vol.24
, pp. 4293-4300
-
-
Abou-Alfa, G.K.1
Schwartz, L.2
Ricci, S.3
Amadori, D.4
Santoro, A.5
Figer, A.6
-
4
-
-
33751242294
-
Leukocytoclastic vasculitis masquerading as hand-foot syndrome in a patient treated with sorafenib
-
Chung NM, Gutierrez M, Turner ML. Leukocytoclastic vasculitis masquerading as hand-foot syndrome in a patient treated with sorafenib. Arch Dermatol 2006;142:1510-1511
-
(2006)
Arch Dermatol
, vol.142
, pp. 1510-1511
-
-
Chung, N.M.1
Gutierrez, M.2
Turner, M.L.3
-
5
-
-
34247589719
-
Yellow skin discoloration associated with sorafenib use for treatment of metastatic renal cell carcinoma
-
Dasanu CA, Alexandrescu DT, Dutcher J. Yellow skin discoloration associated with sorafenib use for treatment of metastatic renal cell carcinoma. South Med J 2007;100:328-330
-
(2007)
South Med J
, vol.100
, pp. 328-330
-
-
Dasanu, C.A.1
Alexandrescu, D.T.2
Dutcher, J.3
-
6
-
-
32444439875
-
Pooled safety ananlysis of BAY 43-9006 (sorafenib) monotherapy in patients with advanced solid tumors: Is rash associated with treatment outcome?
-
Strumberg D, Awada A, Hirte H, Clark JW, Seeber S, Piccart P, et al. Pooled safety ananlysis of BAY 43-9006 (sorafenib) monotherapy in patients with advanced solid tumors: is rash associated with treatment outcome? Eur J Cancer 2006;42:548-556
-
(2006)
Eur J Cancer
, vol.42
, pp. 548-556
-
-
Strumberg, D.1
Awada, A.2
Hirte, H.3
Clark, J.W.4
Seeber, S.5
Piccart, P.6
-
7
-
-
34247361171
-
Hand-foot syndrome and seborrheic dermatitis-like rash induced by sunitinib in a patient with advanced renal cell carcinoma
-
Tsai KY, Yang CH, Kuo TT, Hong HS, Chang JW. Hand-foot syndrome and seborrheic dermatitis-like rash induced by sunitinib in a patient with advanced renal cell carcinoma. J Clin Oncol 2006;24:5786-5788
-
(2006)
J Clin Oncol
, vol.24
, pp. 5786-5788
-
-
Tsai, K.Y.1
Yang, C.H.2
Kuo, T.T.3
Hong, H.S.4
Chang, J.W.5
-
8
-
-
33846924560
-
-
Lai SE, Kuzel T, Lacouture ME. Hand-foot and stump syndrome to sorafenib. J Clin Oncol 2007;25:341-343
-
Lai SE, Kuzel T, Lacouture ME. Hand-foot and stump syndrome to sorafenib. J Clin Oncol 2007;25:341-343
-
-
-
-
9
-
-
4644259265
-
Kinase inhibition with BAY 43-9006 in renal cell carcinoma
-
Ahmed T, Eisen T. Kinase inhibition with BAY 43-9006 in renal cell carcinoma. Clin Cancer Res 2004;10:6388-6392
-
(2004)
Clin Cancer Res
, vol.10
, pp. 6388-6392
-
-
Ahmed, T.1
Eisen, T.2
|